[Recent progress of therapy in patients with Parkinson's disease].
Yanagisawa
N
N
D001921:Brain / Q000473:pathology; D001971:Bromocriptine / Q000494:pharmacology / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D015103:Droxidopa / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000473:pathology / Q000628:therapy*; D011954:Receptors, Dopamine / Q000187:drug effects
D003692:Delayed-Action Preparations; D008996:Monoamine Oxidase Inhibitors; D011954:Receptors, Dopamine; D001971:Bromocriptine; D007980:Levodopa; D015103:Droxidopa